The Global CRISPR Medicine Community will Meet in Copenhagen, April 2025 - 70 speakers, 500 delegates, 30 exhibitors, 200 posters, patient voices...
Save the dates!
Important deadlines:
Meet the CRISPRMED25 Keynote Speaker: Prof. Virginijus Šikšnys
Virginijus is a distinguished professor at Vilnius University and serves as chairman of the board of Life Science Center of Vilnius University. His ground-breaking research on CRISPR-Cas has had a major impact on the gene-editing field, paving the way for the development of novel tools for genome-editing applications.
Virginijus is a member of Academia Europaea, EMBO, Lithuania Academy of Sciences and Norwegian Academy of Sciences and Letters. His work has been recently recognised with numerous awards and prizes including the Kavli Prize.
Sessions included: Tools, Delivery, Safety, Functional Genomics, Pre-clinical, Clinical
Remember to submit your abstract for oral presentation or the poster session before January 17th 2025. 40 abstracts will be selected for an oral presentation.
CRISPRMED25 Sponsors and Supporters
We are excited to welcome Agilent Technologies , Broken String Biosciences and HuidaGene Therapeutics .
Recommended by LinkedIn
View here the full list of confirmed sponsors and supporters of CRISPRMED25.
Interested in CRISPRMED25 Sponsorship Package Information ? Please request more details at: Info@crisprmedicineconference.com. Limited number of packages available.
Are you a student?
As a student/young researcher, you can register for one of the CRISPRMED25/GenE-HumDi COST Action workshops. The workshops will be facilitated by scientific leaders from the GenE-HumDi consortium. The workshop registration is included in the registration fee and there will only be 30 seats available per workshop.
Are you a founder?
The CRISPRMED25 Startup-Investor Event, April 8th, 2025, will connect founders within the CRISPR field with relevant investors and business development people. As a founder you can reserve one of the 15 presentation slots available at this event (included in the registration fee). Register here to reserve one of the speaker slots.
Some of the early-phase startups/investors you will meet:
Meet one of the first CRISPR Medicine patients at CRISPRMED25
Jimi Olaghere is a CASGEVY recipient who has developed a keen interest in the advancements of cell and gene therapies, since his transformative participation in the groundbreaking clinical trial.
At CRISPRMED25, Jimi will share his story about living with sickle cell disease, before and after treatment with the recently approved CRISPR therapy CASGEVY.
Recent Graduate from University of North Carolina at Greensboro, Eager to contribute to Science
1moMay God guide them in this conference